In addition, D cyclins are required for tumor initiation, as mice lacking cyclin D1 are resistant to ErbB2-driven mammary adenocarcinomas [145,148], while cyclin D3 null animals are refractory to Notch1-driven T-ALL [147]. Here, CCND3 is linked to neoplasm.